Intracranial Arteriovenous Malformation
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Cardiovascular Diseases
|
Congenital Abnormality
|
11
|
|
0.200 |
None |
|
0 |
|
|
|
Treatment-resistant schizophrenia
|
disease |
|
Mental or Behavioral Dysfunction
|
23
|
2
|
0.310 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Carcinoma, Pancreatic Ductal
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
82
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Skin Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
363
|
9
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Age related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
685
|
663
|
0.110 |
None |
< 0.001 |
1 |
2
|
2012 |
2012 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Child Development Disorders, Pervasive
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
168
|
379
|
0.100 |
None |
1.000 |
1 |
2
|
2017 |
2017 |
Serum iron measurement
|
phenotype |
|
Laboratory Procedure
|
17
|
25
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cryoglobulinemia
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
37
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Body mass index
|
phenotype |
|
Clinical Attribute
|
1014
|
2689
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Pemphigus Vulgaris
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
115
|
39
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.100 |
None |
1.000 |
1 |
12
|
2007 |
2007 |
Malignant neoplasm of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
173
|
375
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Pulmonary function
|
phenotype |
|
Organ or Tissue Function
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
336
|
93
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
C4 complement assay (procedure)
|
phenotype |
|
Laboratory Procedure
|
12
|
15
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Hip circumference
|
phenotype |
|
Clinical Attribute
|
68
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hepatitis B, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
415
|
84
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Hepatitis C, Chronic
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
430
|
80
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
166
|
374
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
disease |
|
Finding
|
166
|
373
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |